Literature DB >> 9890326

Sickle cell nephropathy.

P Saborio1, J I Scheinman.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 9890326     DOI： 10.1681/ASN.V101187

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  41 in total

1.  Vasculature and kidney complications in sickle cell disease.

Authors:  Karl A Nath; Zvonimir S Katusic
Journal:  J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 10.121

2.  Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease.

Authors:  Julio P Juncos; Joseph P Grande; Narayana Murali; Anthony J Croatt; Luis A Juncos; Robert P Hebbel; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 3.  Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.

Authors:  Uduak Okomo; Martin M Meremikwu
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

4.  Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease.

Authors:  K A Nath; J P Grande; J J Haggard; A J Croatt; Z S Katusic; A Solovey; R P Hebbel
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

5.  Sex dimorphism in serum lecithin: cholesterol acyltransferase and lipoprotein lipase activities in adult sickle cell anaemia patients with proteinuria.

Authors:  M A Emokpae; O H Uwumarongie; H B Osadolor
Journal:  Indian J Clin Biochem       Date:  2010-12-29

6.  Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury.

Authors:  Karl A Nath; Joseph P Grande; Anthony J Croatt; Elena Frank; Noel M Caplice; Robert P Hebbel; Zvonimir S Katusic
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

7.  Combined hydroxyurea and ETA receptor blockade reduces renal injury in the humanized sickle cell mouse.

Authors:  Crystal Taylor; Malgorzata Kasztan; Binli Tao; Jennifer S Pollock; David M Pollock
Journal:  Acta Physiol (Oxf)       Date:  2018-09-20       Impact factor: 6.311

8.  Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

Authors:  Nathalie Sabaa; Lucia de Franceschi; Philippe Bonnin; Yves Castier; Giorgio Malpeli; Haythem Debbabi; Ariane Galaup; Micheline Maier-Redelsperger; Sophie Vandermeersch; Aldo Scarpa; Anne Janin; Bernard Levy; Robert Girot; Yves Beuzard; Christophe Leboeuf; Annie Henri; Stéphane Germain; Jean-Claude Dussaule; Pierre-Louis Tharaux
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 9.  Sickle cell disease.

Authors:  Martin M Meremikwu
Journal:  BMJ Clin Evid       Date:  2009-03-27

10.  Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease.

Authors:  Elsa Maksoud; Berengere Koehl; Aude Facchin; Phuong Ha; Wei Zhao; Florentia Kaguelidou; Malika Benkerrou; Patricia Mariani; Albert Faye; Mathie Lorrot; Evelyne Jacqz-Aigrain
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.